Stefan Zeuzem mostly deals with Internal medicine, Gastroenterology, Hepatitis C virus, Immunology and Ribavirin. His research is interdisciplinary, bridging the disciplines of Viral load and Internal medicine. His Gastroenterology research integrates issues from Randomized controlled trial, Surgery, Peginterferon alfa-2a, Sofosbuvir and Placebo.
His Hepatitis C virus study integrates concerns from other disciplines, such as Alpha interferon and Genotype. The various areas that he examines in his Ribavirin study include Interferon and Pharmacology. His work in Hepatitis C addresses subjects such as Voxilaprevir, which are connected to disciplines such as Pibrentasvir and Glecaprevir.
Stefan Zeuzem focuses on Internal medicine, Gastroenterology, Hepatitis C virus, Ribavirin and Immunology. Internal medicine connects with themes related to Pegylated interferon in his study. His Gastroenterology research is multidisciplinary, relying on both Placebo, Chronic hepatitis and Regimen, Surgery.
The study incorporates disciplines such as Interferon, Viral load and Genotype in addition to Hepatitis C virus. His studies deal with areas such as Alpha interferon and Combination therapy, Pharmacology as well as Ribavirin. His Hepatitis C research includes elements of Viral hepatitis, Clinical trial and Hepatitis.
His scientific interests lie mostly in Internal medicine, Gastroenterology, Cirrhosis, Hepatitis C and Hepatitis C virus. His research links Chronic hepatitis with Internal medicine. His Gastroenterology research incorporates themes from Hepatitis B, Regimen, Hepatocellular carcinoma, Grazoprevir and Elbasvir.
His Cirrhosis research incorporates elements of Inflammation, Systemic inflammation, Immunology, Liver disease and Innate immune system. He combines subjects such as Elbasvir, Grazoprevir, Ribavirin, Meta-analysis and Hepatitis with his study of Hepatitis C. Stefan Zeuzem usually deals with Hepatitis C virus and limits it to topics linked to Genotype and Virology.
Internal medicine, Gastroenterology, Cirrhosis, Hepatitis C virus and Hepatitis C are his primary areas of study. Stefan Zeuzem incorporates Internal medicine and In patient in his research. His biological study spans a wide range of topics, including Hepatitis B, Chronic hepatitis, Regimen, Adverse effect and Clinical endpoint.
His Cirrhosis research is multidisciplinary, incorporating elements of Bilirubin and Organ dysfunction. His Hepatitis C virus study combines topics from a wide range of disciplines, such as Genotype and Hepatitis. His research in Hepatitis C intersects with topics in Hepatocellular carcinoma, Guideline and Virologic response.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Sorafenib in Advanced Hepatocellular Carcinoma
Josep M. Llovet;Sergio Ricci;Vincenzo Mazzaferro;Philip Hilgard.
The New England Journal of Medicine (2008)
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.
Stephanos J. Hadziyannis;Hoel Sette;Timothy R. Morgan;Vijayan Balan.
Annals of Internal Medicine (2004)
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
Thierry Poynard;Patrick Marcellin;Samuel S Lee;Christian Niederau.
The Lancet (1998)
Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
Ira M. Jacobson;John G. McHutchison;Geoffrey Dusheiko;Adrian M. Di Bisceglie.
The New England Journal of Medicine (2011)
Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
Bruce R. Bacon;Stuart C. Gordon;Eric Lawitz;Patrick Marcellin.
The New England Journal of Medicine (2011)
Telaprevir for retreatment of HCV infection.
Stefan Zeuzem;Pietro Andreone;Stanislas Pol;Eric Lawitz.
The New England Journal of Medicine (2011)
Treatment of HCV infection by targeting microRNA
Harry L A Janssen;Hendrik W Reesink;Eric J Lawitz;Stefan Zeuzem.
The New England Journal of Medicine (2013)
Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
Nezam Afdhal;Stefan Zeuzem;Paul Kwo;Mario Chojkier.
The New England Journal of Medicine (2014)
Performance of Transient Elastography for the Staging of Liver Fibrosis: A Meta-Analysis
Mireen Friedrich-Rust;Mei-Fang Ong;Swantje Martens;Christoph Sarrazin.
Gastroenterology (2008)
Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis
Richard Moreau;Rajiv Jalan;Pere Gines;Marco Pavesi.
Gastroenterology (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Goethe University Frankfurt
Goethe University Frankfurt
Hannover Medical School
Hannover Medical School
New York University
Queen Mary University of London
Université Paris Cité
The University of Texas at Austin
Johns Hopkins University School of Medicine
Goethe University Frankfurt
University of Maryland, College Park
University of Washington
Kyushu University
Kyoto Pharmaceutical University
KU Leuven
University of Nantes
Czech Academy of Sciences
University of Dundee
University of Oregon
Institute Curie
Tohoku University
University of California, Riverside
Federal University of Toulouse Midi-Pyrénées
Academia Sinica
St. Jude Children's Research Hospital
National University of Singapore